SightGlass Vision launches, expands myopia management technology for children

EssilorLuxottica and CooperCompanies announced a joint venture agreement for SightGlass Vision, a collaborative initiative created to advance spectacle lens technologies for myopia management in children.

SightGlass Vision’s Diffusion Optics Technology reduces myopia progression in children by incorporating thousands of micro-dots into lenses, which scatter light and reduce contrast on the retina, the companies said in a press release.

“As a global leader with a 30-year track record in myopia research, we have been developing the myopia management category for more than a decade,” Norbert Gorny, co-chief operating officer at EssilorLuxottica, said in the release. “As such, we are thrilled to see our joint venture with CooperCompanies come to life as SightGlass Vision begins to operate, and the first products start to reach the market.”

“Adding spectacle lenses with SightGlass Vision technology to our portfolio of myopia management products translates into better eyesight and brighter lives for countless children,” Dan McBride, chief operating officer and general counsel at CooperCompanies, said. “SightGlass Vision’s commitment to clinically based performance fits well with CooperVision, which has conducted the world’s longest-running myopia management clinical study and is committed to establishing myopia management as a standard of care for affected children.”

Comments are closed.